Hello, Fool! | Login | Signup | My Fool
Dec 2, 2008 12:46 AM ET | Feedback | Site Changes | Help
The Company discovers, develops, manufactures and markets medical therapies and treatments to enhance human health.
View Ticker Page (SGP)
Results 71 - 80 of 156 : « Previous 678910Next »
Recs
dpid (< 20) Submitted: 11/19/08 4:46 PM : Start Price: $15.26 SGP Score: -0.57
drugs + dividends
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
JonBarleycorn (59.97) Submitted: 11/27/08 1:11 AM : Start Price: $16.37 SGP Score: 2.26
T = 1030 /60A = 198 /14Bottom fishing.
nikkobear (< 20) Submitted: 7/09/08 5:11 PM : Start Price: $21.55 SGP Score: 6.17
people will always need meds to cure them
cwlawrence (< 20) Submitted: 7/08/08 8:00 PM : Start Price: $20.59 SGP Score: 11.13
Big Pharmaceuticals are due for a comeback
cmconey08 (< 20) Submitted: 6/17/08 12:59 PM : Start Price: $19.35 SGP Score: 19.91
I see this stock on the current decline but as for the long term this stock will start to pickup in a five year period. Look for the upside after the downside.
lexif (< 20) Submitted: 4/27/08 7:55 PM : Start Price: $18.47 SGP Score: 25.46
Solid company with an exciting new drug, (suggamadex) that is fda approved and will be released shortly. This drug is a significant development in the field of Anesthesia and should lead to significant upside earnings potential.
dhood5445 (< 20) Submitted: 4/30/08 2:20 PM : Start Price: $18.32 SGP Score: 26.35
SGP posted strong first quarter earnings despite the problems with the vytorin, zeita and the enhance trial products. Internationally there has been growth supporting the idea that only the US market will be problematic. A bit of a risk, but isn't e...
deuspecuniae (73.97) Submitted: 5/01/08 12:11 PM : Start Price: $18.58 SGP Score: 24.86
The looming recession that bernanke and the whole federal reserve gang have set this country towards will send alot of investors into the pharmaceutical's sector--being the traditional recessionary savior to say the least. Plus, most pharmaceutical s...
Colli002 (20.30) Submitted: 5/02/08 7:06 AM : Start Price: $18.85 SGP Score: 24.35
Value Play
NJStockGuru (85.90) Submitted: 5/05/08 5:32 PM : Start Price: $18.79 SGP Score: 24.14
Schering-Plough is a top notch company in Big Pharma that was unfairly crucified by the Enhanced study. Vytorin does what it is intended to do - lower cholesterol. They took the results out of context. Furthermore, with their recent acquisitions of O...